Quoromycin
Quoromycin is an orally active SmcR inhibitor with a Kd of 0.697 μM for Vibrio vulnificus SmcR. Quoromycin binds directly to SmcR, reduces its DNA-binding affinity, and inhibits the quorum sensing signaling pathway. Quoromycin is applicable to the research of Vibrio vulnificus infection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 205514-29-0
- 分子式: C12H8N2O2S
- 分子量:244.27
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
Quoromycin (1-50 μM) dose-dependently inhibits the binding of Vibrio vulnificus SmcR to the vvpE promoter DNA without altering SmcR protein levels[1].
Quoromycin (1-50 μM; 25 h) dose-dependently reduces elastase activity in Vibrio vulnificus without inhibiting bacterial growth[1].
Quoromycin (1-50 μM; 12 h) inhibits Vibrio vulnificus vvpE promoter activity with an IC50 of 322 nM[1].
Quoromycin (20 μM) reduces vvpE transcript levels, elastase activity, and exoprotease activity in wild-type Vibrio vulnificus to levels similar to an smcR mutant strain[1].
Quoromycin (1-100 μM; 3 h at 37 °C) dose-dependently reduces Vibrio vulnificus-induced cytotoxicity and bacterial adhesion to INT-407 human intestinal epithelial cells[1].
Quoromycin (20 μM) inhibits quorum sensing in Vibrio harveyi and reduces proteolytic activity in Vibrio anguillarum without inhibiting bacterial growth of either species[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:INT-407 human intestinal epithelial cells infected with Vibrio vulnificus
-
Concentration:1, 10, 25, 50, 100 μM
-
Incubation Time:3 h at 37 °C
-
Result:Reduced Vibrio vulnificus-induced cytotoxicity in INT-407 cells in a dose-dependent manner, with 100 μM quoromycin returning LDH levels to non-infected control levels.
Reduced Vibrio vulnificus adhesion to INT-407 cells in a dose-dependent manner, with 50 μM quoromycin reducing adherent CFUs by half compared to controls.
Quoromycin (122 μg/kg; i.g.; single simultaneous dose with infection) significantly reduces V. vulnificus colonization in mouse small intestine, liver, and spleen, and prevents infection-associated tissue damage[1].
Quoromycin (30-122 μg/kg; i.g.; single dose) shows no acute in vivo cytotoxicity in healthy ICR female mice, with 100% 24-hour survival[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice (female, 7-week-old, pathogen-free)[1]
-
Dosage:61 μg/kg; 122 μg/kg
-
Administration:i.g.; single simultaneous dose with infection
-
Result:Conferred 60% 24-hour survival at 122 μg/kg (vs 10% in untreated controls).
Significantly prolonged survival at 61 μg/kg relative to untreated infected mice.
-
Animal Model:ICR mice (female, pathogen-free)[1]
-
Dosage:122 μg/kg
-
Administration:i.g.; single simultaneous dose with infection
-
Result:Reduced small intestine colonization index to ~-3 log.
Reduced liver colonization index to ~-4.5 log.
Reduced spleen colonization index to ~-5 log.
Prevented edema, hemorrhage, vasodilation, necrosis, and intestinal inflammation/swelling observed in untreated infected mice.
化学情報
-
CAS 番号 205514-29-0
-
分子量 244.27
-
分子式 C12H8N2O2S
-
SMILES
N#CC1=CN=C(C=C1)S(=O)(=O)C=2C=CC=CC2
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Quoromycin 関連分類
HY-W788542 関連分類
Powered by Bioz